BIND THERAPEUTICS INC's ticker is BINDQXXXX and the CUSIP is 05548N107. A total of 43 filers reported holding BIND THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $20,000 | -35.5% | 4,500 | -18.2% | 0.03% | -22.2% |
| Q2 2015 | $31,000 | -34.0% | 5,500 | -35.3% | 0.04% | -36.8% |
| Q1 2015 | $47,000 | +840.0% | 8,500 | +750.0% | 0.06% | +850.0% |
| Q4 2014 | $5,000 | -97.6% | 1,000 | -95.9% | 0.01% | -97.8% |
| Q3 2014 | $210,000 | -50.4% | 24,425 | -20.6% | 0.27% | -55.6% |
| Q2 2014 | $423,000 | +605.0% | 30,750 | +515.0% | 0.61% | +511.0% |
| Q1 2014 | $60,000 | +160.9% | 5,000 | +233.3% | 0.10% | +185.7% |
| Q4 2013 | $23,000 | – | 1,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 2,018,253 | $9,001,000 | 6.13% |
| FNY Managed Accounts LLC | 30,000 | $133,800,000 | 0.37% |
| Rhenman & Partners Asset Management AB | 133,535 | $596,000 | 0.10% |
| THOMPSON DAVIS & CO., INC. | 4,500 | $20,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 26,000 | $116,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,593 | $373,000 | 0.01% |
| VANGUARD GROUP INC | 5,488,396 | $177,885,000 | 0.01% |
| Alyeska Investment Group, L.P. | 114,786 | $512,000 | 0.01% |
| Renaissance Technologies | 269,300 | $1,201,000 | 0.00% |
| PRINCIPAL FINANCIAL GROUP INC | 324,900 | $1,449,000 | 0.00% |